Literature DB >> 19304298

Prediction of long-term outcome by percent improvement after the first day of thrombolytic treatment in stroke patients.

Hyo Suk Nam1, Kyung-Yul Lee, Sang Won Han, Seo Hyun Kim, Jong Yun Lee, Seong Hwan Ahn, Dong Joon Kim, Dong Ik Kim, Chung Mo Nam, Ji Hoe Heo.   

Abstract

BACKGROUND: We investigated a method for assessing early improvement and predictive factors of early and late outcomes in patients receiving thrombolytic therapy.
METHODS: A total of 160 consecutive patients who received thrombolytic therapy were included in the study. Using National Institutes of Health Stroke Scale (NIHSS) scores, percent improvement [(baseline NIHSS score-24-hour NIHSS score)/baseline NIHSS score x 100] was calculated and compared with delta (baseline NIHSS score-24-hour NIHSS score) and with major neurological improvement (MNI, NIHSS score of 0-1 or >or=8 point improvement at 24 h) by receiver operating characteristic (ROC) curve analysis. Finally, we investigated the independent predictors of improvement at 24 h after the thrombolytic therapy and of favorable 3-month outcome (modified Rankin scale score 0-2).
RESULTS: By pairwise comparison of ROC curves, percent improvement was stronger than delta (p=0.004) and MNI (p<0.001) in predicting long-term outcome. First day improvement (FDI), defined as greater than 20% improvement, was a strong predictor of favorable 3-month outcome (OR 12.55, 95% CI 5.41-29.10). Recanalization (OR 3.30, 95% CI 1.28-8.45), absence of carotid T occlusion (OR 0.09, 95% CI 0.02-0.42) and hemorrhagic transformation (OR 0.25, 95% CI 0.09-0.73) were independent predictors of FDI. Independent predictors of favorable 3-month outcome were FDI, current smoking, absence of carotid T occlusion and hemorrhagic transformation.
CONCLUSIONS: Percent improvement at 24 h after thrombolytic therapy is a useful surrogate marker for predicting the long-term outcome. Our findings highlight the importance of early stroke management.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19304298     DOI: 10.1016/j.jns.2009.02.365

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  15 in total

1.  Rapid Neurologic Improvement Predicts Favorable Outcome 90 Days After Thrombectomy in the DEFUSE 3 Study.

Authors:  Jeremy J Heit; Michael Mlynash; Stephanie M Kemp; Maarten G Lansberg; Soren Christensen; Michael P Marks; Santiago Ortega-Gutierrez; Gregory W Albers
Journal:  Stroke       Date:  2019-05       Impact factor: 7.914

2.  Statin pretreatment is associated with better outcomes in large artery atherosclerotic stroke.

Authors:  Georgios Tsivgoulis; Aristeidis H Katsanos; Vijay K Sharma; Christos Krogias; Robert Mikulik; Konstantinos Vadikolias; Milija Mijajlovic; Apostolos Safouris; Christina Zompola; Simon Faissner; Viktor Weiss; Sotirios Giannopoulos; Spyros Vasdekis; Efstathios Boviatsis; Anne W Alexandrov; Konstantinos Voumvourakis; Andrei V Alexandrov
Journal:  Neurology       Date:  2016-02-24       Impact factor: 9.910

3.  Which patients with acute stroke due to proximal occlusion should not be treated with endovascular thrombectomy?

Authors:  Mayank Goyal; Mohammed A Almekhlafi; Christoph Cognard; Ryan McTaggart; Kristine Blackham; Alessandra Biondi; Aad van der Lugt; Charles B L M Majoie; Wim H van Zwam; H Bart van der Worp; Michael D Hill
Journal:  Neuroradiology       Date:  2019-01       Impact factor: 2.804

4.  Redefined Measure of Early Neurological Improvement Shows Treatment Benefit of Alteplase Over Placebo.

Authors:  Shashank Agarwal; Erica Scher; Aaron Lord; Jennifer Frontera; Koto Ishida; Jose Torres; Sara Rostanski; Eva Mistry; Brian Mac Grory; Shawna Cutting; Tina Burton; Brian Silver; Ava L Liberman; Mackenzie P Lerario; Karen Furie; James Grotta; Pooja Khatri; Jeffrey Saver; Shadi Yaghi
Journal:  Stroke       Date:  2020-02-27       Impact factor: 7.914

5.  Delayed neurological improvement is predictive to long-term clinical outcome on endovascular thrombectomy patients.

Authors:  Haodi Cai; Yunfei Han; Wen Sun; Mingming Zha; Xuan Shi; Kangmo Huang; Qingwen Yang; Xiaoke Wang; Rui Liu; Xinfeng Liu
Journal:  Interv Neuroradiol       Date:  2021-09-13       Impact factor: 1.764

6.  Serum uri acid: neuroprotection in thrombolysis. The Bergen NORSTROKE study.

Authors:  Nicola Logallo; Halvor Naess; Titto T Idicula; Jan Brogger; Ulrike Waje-Andreassen; Lars Thomassen
Journal:  BMC Neurol       Date:  2011-09-25       Impact factor: 2.474

7.  Predictors of Outcomes in Patients With Mild Ischemic Stroke Symptoms: MaRISS.

Authors:  Jose G Romano; Hannah Gardener; Iszet Campo-Bustillo; Yosef Khan; Sofie Tai; Nikesha Riley; Eric E Smith; Ralph L Sacco; Pooja Khatri; Heather M Alger; Brian Mac Grory; Deepak Gulati; Navdeep S Sangha; Jeffrey M Craig; Karin E Olds; Curtis G Benesch; Adam G Kelly; Scott S Brehaut; Amit C Kansara; Lee H Schwamm
Journal:  Stroke       Date:  2021-05-05       Impact factor: 10.170

8.  Repeated thrombolytic therapy in patients with recurrent acute ischemic stroke.

Authors:  Han Soo Yoo; Young Dae Kim; Hye Sun Lee; Dongbeom Song; Tae Jin Song; Byung Moon Kim; Dong Joon Kim; Dong Ik Kim; Ji Hoe Heo; Hyo Suk Nam
Journal:  J Stroke       Date:  2013-09-27       Impact factor: 6.967

9.  Effect and Safety of Rosuvastatin in Acute Ischemic Stroke.

Authors:  Ji Hoe Heo; Dongbeom Song; Hyo Suk Nam; Eung Yeop Kim; Young Dae Kim; Kyung-Yul Lee; Ki-Jeong Lee; Joonsang Yoo; Youn Nam Kim; Byung Chul Lee; Byung-Woo Yoon; Jong S Kim
Journal:  J Stroke       Date:  2016-01-29       Impact factor: 6.967

10.  Prediction of Outcome in Patients With Acute Ischemic Stroke Based on Initial Severity and Improvement in the First 24 h.

Authors:  Anke Wouters; Céline Nysten; Vincent Thijs; Robin Lemmens
Journal:  Front Neurol       Date:  2018-05-07       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.